Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion

被引:89
作者
Mingrone, G. [1 ]
Nolfe, G. [2 ]
Gissey, G. Castagneto [3 ]
Iaconelli, A. [1 ]
Leccesi, L. [1 ]
Guidone, C. [1 ]
Nanni, G. [4 ]
Holst, J. J. [5 ]
机构
[1] Univ Cattolica Sacro Cuore, Dept Internal Med, I-00168 Rome, Italy
[2] Inst Cybernet E Caianiello, CNR, Pozzuoli, Italy
[3] Univ Kent, Dept Econ, Canterbury, Kent, England
[4] Univ Cattolica Sacro Cuore, Dept Surg, I-00168 Rome, Italy
[5] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-2200 Copenhagen, Denmark
关键词
Bariatric surgery; Circadian rhythm; GIP; GLP1; Morbid obesity; GASTRIC-INHIBITORY POLYPEPTIDE; BETA-CELL FUNCTION; INSULIN-RESISTANCE; BARIATRIC SURGERY; INCRETIN LEVELS; BYPASS-SURGERY; OBESE-PATIENTS; BODY-WEIGHT; SECRETION; MELLITUS;
D O I
10.1007/s00125-009-1288-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We tested the hypothesis that the reversibility of insulin resistance and diabetes observed after biliopancreatic diversion (BPD) is related to changes in circadian rhythms of gastrointestinal hormones. Ten morbidly obese participants, five with normal glucose tolerance (NGT) and five with type 2 diabetes, were studied before and within 2 weeks after BPD. Within-day variations in glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP1) levels were assessed using a single cosinor model. Insulin sensitivity was assessed by euglycaemic-hyperinsulinaemic clamp. Basal GLP1 relative amplitude (amplitude/mesor x 100) was 25.82-4.06% in NGT; it increased to 41.38-4.32% after BPD but was unchanged in diabetic patients. GLP1 and GIP mesor were shifted in time after surgery in diabetic patients but not in NGT participants. After BPD, the GLP1 AUC significantly increased from 775 +/- 94 to 846 +/- 161 pmol l(-1) min in NGT, whereas GIP AUC decreased significantly from 1,373 +/- 565 to 513 +/- 186 pmol l(-1) min in diabetic patients. Two-way ANOVA showed a strong influence of BPD on both GIP (p = 0.010) and GLP1 AUCs (p = 0.033), which was potentiated by the presence of diabetes, particularly for GIP (BPD x diabetes, p = 0.003). Insulin sensitivity was markedly improved (p < 0.01) in NGT (from 9.14 +/- 3.63 to 36.04 +/- 8.55 A mu mol [kg fat-free mass](-1) min(-1)) and diabetic patients (from 9.49 A +/- 3.56 to 38.57 A +/- 4.62 A mu mol [kg fat-free mass](-1) min(-1)). An incretin circadian rhythm was shown for the first time in morbid obesity. The effect of BPD on the 24 h pattern of incretin differed between NGT and diabetic patients. GLP1 secretion impairment was reversed in NGT and could not be overcome by surgery in diabetes. On the other hand, GIP secretion was blunted after the operation only in diabetic patients, suggesting a role in insulin resistance and diabetes.
引用
收藏
页码:873 / 881
页数:9
相关论文
共 29 条
  • [1] Weight loss and long-term follow-up of severely obese individuals treated with an intense behavioral program
    Anderson J.W.
    Grant L.
    Gotthelf L.
    Stifler L.T.P.
    [J]. International Journal of Obesity, 2007, 31 (3) : 488 - 493
  • [2] β-cell function in severely obese type 2 diabetic patients -: Long-term effects of bariatric surgery
    Camastra, Stefania
    Manco, Melania
    Mari, Andrea
    Greco, Aldo V.
    Frascerra, Silvia
    Mingrone, Geltrude
    Ferrannini, Ele
    [J]. DIABETES CARE, 2007, 30 (04) : 1002 - 1004
  • [3] Immunocytochemical evidence for a paracrine interaction between GIP and GLP-1-producing cells in canine small intestine
    Damholt, AB
    Kofod, H
    Buchan, AMJ
    [J]. CELL AND TISSUE RESEARCH, 1999, 298 (02) : 287 - 293
  • [4] DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
  • [5] PLASMA-IMMUNOREACTIVE GASTRIC-INHIBITORY POLYPEPTIDE IN OBESE HYPERGLYCEMIC (OB/OB) MICE
    FLATT, PR
    BAILEY, CJ
    KWASOWSKI, P
    PAGE, T
    MARKS, V
    [J]. JOURNAL OF ENDOCRINOLOGY, 1984, 101 (03) : 249 - 256
  • [6] Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes
    Gault, VA
    Irwin, N
    Green, BD
    McCluskey, JT
    Greer, B
    Bailey, CJ
    Harriott, P
    O'Harte, FPM
    Flatt, PR
    [J]. DIABETES, 2005, 54 (08) : 2436 - 2446
  • [7] Link between obesity and type 2 diabetes
    Golay, A
    Ybarra, J
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 19 (04) : 649 - 663
  • [8] Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery
    Guidone, Caterina
    Manco, Melania
    Valera-Mora, Elena
    Iaconelli, Amerigo
    Gniuli, Donatella
    Mari, Andrea
    Nanni, Giuseppe
    Castagneto, Marco
    Calvani, Menotti
    Mingrone, Geltrude
    [J]. DIABETES, 2006, 55 (07) : 2025 - 2031
  • [9] DIMINISHED IMMUNOREACTIVE GASTRIC-INHIBITORY POLYPEPTIDE RESPONSE TO A MEAL IN NEWLY DIAGNOSED TYPE-I (INSULIN DEPENDENT) DIABETICS
    KRARUP, T
    MADSBAD, S
    MOODY, AJ
    REGEUR, L
    FABER, OK
    HOLST, JJ
    SESTOFT, L
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (06) : 1306 - 1312
  • [10] Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes
    Laferrere, Blandine
    Teixeira, Julio
    McGinty, James
    Tran, Hao
    Egger, Joseph R.
    Colarusso, Antonia
    Kovack, Betty
    Bawa, Baani
    Koshy, Ninan
    Lee, Hongchan
    Yapp, Kimberly
    Olivan, Blanca
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (07) : 2479 - 2485